Hormonal

Calcitonin

Also known as: Miacalcin, Fortical, Salmon Calcitonin

FDA Approved
Share:

Key Facts: Calcitonin

Category
Hormonal
FDA Status
FDA Approved
Clinical Status
FDA Approved - Osteoporosis and Paget's disease
Administration
Intranasal spray or injection
Typical Dose
Limited community data available
Frequency
See research protocols
Evidence Level
FDA Approved
Duration
Long-term for osteoporosis
Also Known As
Miacalcin, Fortical, Salmon Calcitonin

What to Expect

A thyroid hormone that inhibits bone resorption. FDA approved for osteoporosis and Paget's disease. Also used for hypercalcemia.

Mechanism of Action

Calcitonin binds to osteoclast receptors, inhibiting bone breakdown. It also reduces renal calcium reabsorption and has analgesic effects on bone pain through mechanisms not fully understood.

Research Summary

Salmon calcitonin is 40-50x more potent than human. Studies show modest fracture reduction and significant bone pain relief. Nasal spray formulation improved compliance over injection.

Clinical Status:FDA Approved - Osteoporosis and Paget's disease
Trial Progress:FDA Approved
Pre
I
II
III
IV
FDA

Dosing Information

FDA Approved·Human clinical trials completed, FDA approved

Typical Dosing

Community experience

Common Dose

Limited community data available

Range

See research dosing

Frequency

See research protocols

Research Dosing

Scientific studies

FDA-approved dosing

Doses from Studies

Duration

Long-term for osteoporosis

Administration

Intranasal spray or injection

Timing & Administration

Best Time to Take

Morning or as directed

Follow recommended protocol

Food Recommendation

With or without food

Why This Timing?

Timing may vary based on individual response and goals. Consistency is generally more important than specific timing.

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

  • Nausea (10%)
  • Injection site reactions
  • Facial flushing
  • Nasal symptoms (spray)
  • Hypocalcemia
  • Anaphylaxis (rare)
  • Increased malignancy risk in meta-analysis
  • FDA approved

References

Related Peptides

Peptides commonly compared with Calcitonin or used in similar applications.

Want updates on Calcitonin research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.

Educational Information Only

This information is provided for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare providers before making any decisions about peptides or other substances. The protocols listed reflect doses observed in research studies, not recommendations.